Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q86UL3

Entry ID Method Resolution Chain Position Source
AF-Q86UL3-F1 Predicted AlphaFoldDB

251 variants for Q86UL3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs534990402
CA4726461
2 F>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs201982831
CA4726462
9 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4726463
rs777623777
11 I>M No ClinGen
ExAC
gnomAD
CA4726464
rs749192194
12 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs554740180
CA4726465
13 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1585660191
CA371043442
17 I>L No ClinGen
Ensembl
rs745525354
CA4726468
21 V>I No ClinGen
ExAC
gnomAD
CA371043491
rs1329560534
22 L>F No ClinGen
TOPMed
CA371043490
rs1329560534
22 L>V No ClinGen
TOPMed
rs1585660222
CA371043510
24 T>P No ClinGen
Ensembl
rs1361225602
CA371043530
26 L>I No ClinGen
gnomAD
TCGA novel 27 L>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760142023
CA4726471
27 L>F No ClinGen
ExAC
gnomAD
CA4726473
rs375002166
28 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4726474
rs762266933
30 I>V No ClinGen
ExAC
gnomAD
COSM1182229
rs765600184
CA4726475
31 I>T large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA371043581
rs1384211933
31 I>V No ClinGen
TOPMed
TCGA novel 32 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768242581
CA175907167
34 A>V No ClinGen
Ensembl
CA371043635
rs1280533019
37 G>R No ClinGen
gnomAD
rs1585660295
CA371043671
42 I>T No ClinGen
Ensembl
CA175907179
rs969162986
42 I>V No ClinGen
gnomAD
CA4726480
rs755038220
43 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA175907183
rs866666749
COSM486468
43 R>H kidney Variant assessed as Somatic; impact. central_nervous_system endometrium prostate [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA371043696
rs1243226268
46 Y>C No ClinGen
gnomAD
rs781295731
CA4726481
47 M>T No ClinGen
ExAC
gnomAD
CA371043709
rs1301317642
48 K>E No ClinGen
TOPMed
gnomAD
TCGA novel 49 S>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 50 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 53 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs778977102
CA4726484
55 A>V No ClinGen
ExAC
gnomAD
rs1372109334
CA371045995
61 M>I No ClinGen
TOPMed
rs1275622185
CA371045976
61 M>T No ClinGen
gnomAD
CA175911517
rs866267744
62 E>Q No ClinGen
gnomAD
TCGA novel 63 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4726507
rs377030711
63 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA371046105
rs1236795465
67 E>Q No ClinGen
gnomAD
CA4726508
rs747697851
69 N>K No ClinGen
ExAC
gnomAD
rs1182090751
CA371046191
71 Q>* No ClinGen
gnomAD
rs1166503660
CA371046209
72 L>F No ClinGen
TOPMed
CA175911527
rs962349795
75 P>L No ClinGen
Ensembl
rs1367474784
CA371046291
77 T>P No ClinGen
gnomAD
CA371046376
rs1276884119
79 G>A No ClinGen
gnomAD
CA371046319
rs1563276951
79 G>R No ClinGen
Ensembl
rs772540537
CA4726532
84 D>V No ClinGen
ExAC
gnomAD
CA4726533
rs775875846
85 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA371046525
rs1343293234
87 S>L No ClinGen
gnomAD
rs1327307604
CA371046540
88 L>V No ClinGen
TOPMed
TCGA novel 89 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371046665
rs1288022006
92 I>M No ClinGen
TOPMed
rs985928396
CA175911610
93 K>E No ClinGen
TOPMed
rs1280514007
CA371046678
93 K>R No ClinGen
gnomAD
CA175911612
rs755071830
COSM1099839
96 R>C Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA175911613
rs372267172
96 R>H No ClinGen
ESP
gnomAD
rs781072925
CA175911615
97 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs781072925
CA4726536
97 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4726537
rs761795294
98 S>I No ClinGen
ExAC
gnomAD
rs751431517
CA4726539
99 G>D No ClinGen
ExAC
gnomAD
rs557789924
CA4726538
99 G>S No ClinGen
1000Genomes
ExAC
gnomAD
rs1375787922
CA371046782
101 S>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs759349840
CA4726540
101 S>N No ClinGen
ExAC
gnomAD
rs759349840
CA371046784
101 S>T No ClinGen
ExAC
gnomAD
TCGA novel 102 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371046803
rs1204002620
103 A>T No ClinGen
gnomAD
CA371046814
rs1175774828
104 L>M No ClinGen
gnomAD
CA4726541
rs767261622
104 L>P No ClinGen
ExAC
gnomAD
CA4726542
rs752353760
105 D>G No ClinGen
ExAC
gnomAD
CA175911634
rs934038413
105 D>N No ClinGen
TOPMed
CA371046881
rs1287235071
106 N>S No ClinGen
gnomAD
CA4726543
rs755709726
109 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs753450693
CA371046974
111 E>* No ClinGen
ExAC
gnomAD
CA4726545
rs753450693
111 E>K No ClinGen
ExAC
gnomAD
CA371047020
rs1563277120
114 D>N No ClinGen
Ensembl
rs1236875142
CA371047053
115 I>V No ClinGen
gnomAD
rs779520353
CA175911658
120 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs779520353
COSM1489289
CA4726547
120 R>Q Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1352474249
CA371047162
120 R>W No ClinGen
gnomAD
CA371047197
rs1585670074
122 G>R No ClinGen
Ensembl
rs746325761
CA4726548
123 M>I No ClinGen
ExAC
gnomAD
CA371047285
rs1563277144
126 I>V No ClinGen
Ensembl
TCGA novel 133 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371047457
rs1427633989
137 A>P No ClinGen
TOPMed
CA4726554
rs776686044
141 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA4726555
rs762003163
142 S>A No ClinGen
ExAC
gnomAD
CA4726556
rs769715619
142 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs1563277175
CA371047503
COSM318595
143 W>C lung [Cosmic] No ClinGen
cosmic curated
Ensembl
rs1347110962
CA371047530
147 S>R No ClinGen
gnomAD
CA4726558
rs759404870
149 T>S No ClinGen
ExAC
gnomAD
rs1487585042
CA371047547
150 N>I No ClinGen
TOPMed
gnomAD
rs1487585042
CA371047546
150 N>S No ClinGen
TOPMed
gnomAD
CA175911694
rs267601921
154 Q>* No ClinGen
Ensembl
CA4726560
rs752549936
154 Q>R No ClinGen
ExAC
gnomAD
rs763844705
CA4726562
159 R>Q No ClinGen
ExAC
gnomAD
rs760455234
CA4726561
159 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1211015184
CA371047626
160 L>V No ClinGen
TOPMed
TCGA novel 161 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1243368199
CA371047646
162 V>F No ClinGen
TOPMed
gnomAD
rs1243368199
COSM1457066
CA371047643
162 V>I Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA4726567
rs758917144
165 G>A No ClinGen
ExAC
gnomAD
CA175911715
rs971058322
168 V>M No ClinGen
Ensembl
CA175911721
rs1002596164
COSM1099840
171 R>W Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA371047792
rs1319325108
173 C>G No ClinGen
TOPMed
CA371047833
rs1410370816
175 L>P No ClinGen
gnomAD
rs1164125493
CA371047862
177 P>L No ClinGen
gnomAD
CA4726572
rs781500138
179 R>G No ClinGen
ExAC
gnomAD
TCGA novel 180 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746883357
CA4726597
180 I>M No ClinGen
ExAC
gnomAD
CA371048230
rs1213591396
181 A>T No ClinGen
gnomAD
rs1211834933
CA371048259
185 T>I No ClinGen
gnomAD
CA4726599
rs776233376
189 L>P No ClinGen
ExAC
gnomAD
rs145222803
CA4726601
194 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371048330
rs1180479690
197 V>A No ClinGen
TOPMed
gnomAD
rs747762111
CA175911926
197 V>M No ClinGen
Ensembl
CA4726602
rs772976570
200 L>V No ClinGen
ExAC
gnomAD
rs762573991
CA4726603
203 G>W No ClinGen
ExAC
gnomAD
rs767946041
CA4726624
204 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA371048407
rs1459861767
207 E>* No ClinGen
gnomAD
rs1166999453
CA371048410
207 E>V No ClinGen
gnomAD
rs1394945153
CA371048422
209 M>V No ClinGen
gnomAD
CA371048451
rs1178099968
212 H>R No ClinGen
TOPMed
rs144971917
CA4726627
213 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs757415755
CA4726629
219 R>Q No ClinGen
ExAC
gnomAD
rs1275110506
CA371048500
219 R>W No ClinGen
TOPMed
rs750536765
CA4726631
222 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs758473461
CA4726632
COSM1099841
223 R>* Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA371048524
rs1195551029
223 R>Q No ClinGen
gnomAD
CA371048529
rs1248819678
224 A>T No ClinGen
TOPMed
gnomAD
CA4726633
rs181217466
224 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1327294593
CA371048539
226 T>A No ClinGen
TOPMed
CA371048569
rs1167021342
229 I>F No ClinGen
gnomAD
CA4726636
rs777651640
230 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA371048584
rs1304452731
230 T>I No ClinGen
gnomAD
CA371048603
rs1165984834
232 H>R No ClinGen
gnomAD
rs377666224
CA4726637
232 H>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 234 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 236 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371048676
rs1293970965
238 P>A No ClinGen
gnomAD
rs757092018
CA4726656
238 P>R No ClinGen
ExAC
gnomAD
CA371048679
rs1359375938
239 R>G No ClinGen
TOPMed
CA371048693
rs1563278173
240 N>K No ClinGen
Ensembl
rs1563278170
CA371048690
240 N>S No ClinGen
Ensembl
rs778456881
CA4726657
241 G>C No ClinGen
ExAC
TOPMed
gnomAD
rs1041454554
CA175912488
244 C>Y No ClinGen
TOPMed
CA4726658
rs745496588
246 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs1311657925
CA371048773
248 H>R No ClinGen
TOPMed
CA371048784
rs1212555952
249 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4726661
rs746510734
COSM1099843
251 P>L Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4726660
rs775009661
251 P>T No ClinGen
ExAC
gnomAD
rs1428923387
CA371048801
252 I>V No ClinGen
gnomAD
CA4726665
rs765596568
260 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs143037095
CA4726667
262 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4726666
rs773310525
262 Y>D No ClinGen
ExAC
gnomAD
rs143037095
CA371048937
262 Y>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 264 A>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1329229940
CA371049532
267 G>A No ClinGen
gnomAD
rs1477735109
CA371049591
271 G>R No ClinGen
TOPMed
CA371049609
rs1336702973
272 G>E No ClinGen
gnomAD
CA4726693
rs765075072
274 M>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371049670
rs1480459126
277 I>F No ClinGen
gnomAD
rs765318607
CA175912718
280 A>V No ClinGen
Ensembl
rs750301619
CA4726694
282 V>L No ClinGen
ExAC
gnomAD
rs368929609
CA4726695
284 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1187881943
CA371049808
286 P>R No ClinGen
gnomAD
rs751164953
CA175912730
288 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs751164953
CA4726697
288 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1563278482
CA371049867
289 W>C No ClinGen
Ensembl
CA175912738
rs371903817
291 E>D No ClinGen
ESP
TOPMed
rs754488446
CA4726698
291 E>K No ClinGen
ExAC
gnomAD
CA371049893
rs1460211123
292 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1299459008
CA371049897
292 R>H No ClinGen
TOPMed
gnomAD
rs1299459008
CA371049895
292 R>L No ClinGen
TOPMed
gnomAD
CA371049909
rs1413571473
293 S>L No ClinGen
gnomAD
rs1427920537
CA371049923
294 E>D No ClinGen
gnomAD
rs1416576424
CA371049928
295 V>L No ClinGen
TOPMed
rs1338577920
CA371049947
296 K>N No ClinGen
TOPMed
rs770397529
CA4726701
298 R>C No ClinGen
ExAC
gnomAD
CA371049966
rs1228798384
298 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1419161534
CA371050007
303 K>E No ClinGen
Ensembl
rs1190951657
CA371050070
306 T>A No ClinGen
gnomAD
CA4726724
rs749715016
307 E>K No ClinGen
ExAC
gnomAD
rs771335510
CA4726725
308 H>P No ClinGen
ExAC
gnomAD
rs78295909
CA4726726
308 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs746223695
CA4726727
309 V>L No ClinGen
ExAC
gnomAD
rs772493321
CA4726728
311 D>E No ClinGen
ExAC
gnomAD
CA371050105
rs1238673251
311 D>G No ClinGen
TOPMed
rs72638927
CA4726730
312 K>I No ClinGen
ExAC
gnomAD
rs1343323122
CA371050129
314 K>N No ClinGen
TOPMed
gnomAD
rs768569811
CA4726731
319 I>V No ClinGen
ExAC
gnomAD
CA371050163
rs1220771897
320 F>V No ClinGen
TOPMed
TCGA novel 334 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4726747
rs747159361
338 S>G No ClinGen
ExAC
gnomAD
CA4726748
rs374853413
341 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1585674873
CA371050395
346 Y>S No ClinGen
Ensembl
CA4726750
rs374624501
349 A>G No ClinGen
ESP
ExAC
gnomAD
rs1212167469
CA371050435
350 I>M No ClinGen
gnomAD
rs1167582807
CA371050893
358 D>N No ClinGen
gnomAD
rs1431828528
CA371050965
364 S>N No ClinGen
TOPMed
gnomAD
rs1423307177
CA371050999
367 G>R No ClinGen
TOPMed
CA4726771
rs774300566
368 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs1467841263
CA371051038
370 T>A No ClinGen
TOPMed
rs777945418
CA4726772
374 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1227098443
CA371051086
375 M>L No ClinGen
gnomAD
rs771864075
CA4726773
COSM1099845
CA371051106
376 M>I endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA371051110
rs1585678238
377 T>P No ClinGen
Ensembl
rs1228661101
CA371051123
378 S>N No ClinGen
gnomAD
rs1585678251
CA371051132
379 W>G No ClinGen
Ensembl
CA371051156
rs1279068173
380 A>V No ClinGen
gnomAD
CA371051161
rs1563280779
381 I>V No ClinGen
Ensembl
CA4726774
rs775210430
382 V>A No ClinGen
ExAC
gnomAD
rs776328407
CA4726778
385 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA4726777
rs776328407
385 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA371051221
rs1585678287
387 Y>S No ClinGen
Ensembl
rs1313649685
CA371051242
389 P>S No ClinGen
TOPMed
CA175915414
rs764802073
390 P>H No ClinGen
ExAC
TOPMed
gnomAD
CA4726779
rs764802073
390 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1300781541
CA371051247
390 P>S No ClinGen
TOPMed
CA175915420
rs946151758
391 M>K No ClinGen
TOPMed
gnomAD
CA4726780
rs750971120
391 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1384862026
CA371051272
392 T>S No ClinGen
TOPMed
rs776455733
CA4726794
395 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA4726795
rs761493151
397 E>G No ClinGen
ExAC
gnomAD
rs1225680309
CA371051828
397 E>K No ClinGen
TOPMed
rs772923260
CA4726797
398 D>G No ClinGen
ExAC
gnomAD
rs1314022876
CA371051891
401 Q>R No ClinGen
TOPMed
TCGA novel 403 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA175922710
rs878930531
404 N>Y No ClinGen
Ensembl
rs1312511288
CA371052178
418 D>G No ClinGen
TOPMed
TCGA novel 418 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4726804
rs772946390
420 L>Q No ClinGen
ExAC
rs1254042510
CA371052305
423 G>R No ClinGen
gnomAD
rs375253090
CA4726817
428 E>K No ClinGen
ESP
ExAC
gnomAD
rs748770051
CA371052350
429 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA371052348
rs1165076531
429 K>R No ClinGen
gnomAD
CA4726820
rs143006137
433 T>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4726819
rs143006137
433 T>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4726822
rs767995915
436 E>K No ClinGen
ExAC
gnomAD
rs1300950410
CA371052409
438 Q>K No ClinGen
gnomAD
CA371052458
rs1294548862
444 K>R No ClinGen
gnomAD
CA371052472
rs1341781737
446 I>V No ClinGen
gnomAD
CA175923500
rs963843628
447 V>L No ClinGen
gnomAD
rs1483387146
CA371052486
448 G>E No ClinGen
gnomAD
CA4726824
rs760999237
449 N>S No ClinGen
ExAC
gnomAD
rs1585679975
CA371052502
450 H>Q No ClinGen
Ensembl
CA371052505
rs1236183522
451 K>E No ClinGen
gnomAD
rs1585679996
CA371052515
452 D>A No ClinGen
Ensembl
rs1484505834
CA371052518
452 D>E No ClinGen
gnomAD
rs1585679983
CA371052514
452 D>Y No ClinGen
Ensembl
CA4726825
rs764351730
453 R>G No ClinGen
ExAC
CA175923508
rs971551778
454 S>I No ClinGen
TOPMed
rs750624557
CA175923510
455 R>C No ClinGen
Ensembl
rs1419230409
CA371052535
455 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD

No associated diseases with Q86UL3

2 regional properties for Q86UL3

Type Name Position InterPro Accession
domain Phospholipid/glycerol acyltransferase 229 - 353 IPR002123
domain Lysophosphatidylcholine acyltransferase LPCAT1-like 218 - 427 IPR045252

Functions

Description
EC Number 2.3.1.15 Transferring groups other than amino-acyl groups
Subcellular Localization
  • Endoplasmic reticulum membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

3 GO annotations of molecular function

Name Definition
1-acylglycerol-3-phosphate O-acyltransferase activity Catalysis of the reaction: acyl-CoA + 1-acyl-sn-glycerol-3-phosphate = CoA + 1,2-diacyl-sn-glycerol-3-phosphate.
glycerol-3-phosphate O-acyltransferase activity Catalysis of the reaction: acyl-CoA + sn-glycerol 3-phosphate = CoA + 1-acyl-sn-glycerol 3-phosphate.
sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity Catalysis of the reaction: hexadecanedioyl-CoA + sn-glycerol 3-phosphate = coenzyme A + 1-C16:0-alpha,omega-dicarboxyl-2-lysophosphatidate.

11 GO annotations of biological process

Name Definition
acyl-CoA metabolic process The chemical reactions and pathways involving acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with an acyl group.
CDP-diacylglycerol biosynthetic process The chemical reactions and pathways resulting in the formation of CDP-diacylglycerol, CDP-1,2-diacylglycerol, a substance composed of diacylglycerol in glycosidic linkage with cytidine diphosphate.
diacylglycerol metabolic process The chemical reactions and pathways involving diacylglycerol, a glyceride in which any two of the R groups (positions not specified) are acyl groups while the remaining R group can be either H or an alkyl group.
fatty acid metabolic process The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
glandular epithelial cell maturation The developmental process, independent of morphogenetic (shape) change, that is required for a glandular epithelial cell to attain its fully functional state. A glandular epithelial cell is a columnar/cuboidal epithelial cell is a cell found in a two dimensional sheet with a free surface exposed to the lumen of a gland.
lactation The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young.
lipid biosynthetic process The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
phosphatidic acid biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidic acid, any derivative of glycerol phosphate in which both the remaining hydroxyl groups of the glycerol moiety are esterified with fatty acids.
phosphatidylcholine biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.
regulation of multicellular organism growth Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
triglyceride biosynthetic process The chemical reactions and pathways resulting in the formation of a triglyceride, any triester of glycerol.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A3FPG8 GPAT4 Glycerol-3-phosphate acyltransferase 4 Bos taurus (Bovine) PR
Q5ZLL8 GPAT3 Glycerol-3-phosphate acyltransferase 3 Gallus gallus (Chicken) PR
Q9Y679 AUP1 Lipid droplet-regulating VLDL assembly factor AUP1 Homo sapiens (Human) PR
Q8NF37 LPCAT1 Lysophosphatidylcholine acyltransferase 1 Homo sapiens (Human) PR
Q8C0N2 Gpat3 Glycerol-3-phosphate acyltransferase 3 Mus musculus (Mouse) PR
Q8K2C8 Gpat4 Glycerol-3-phosphate acyltransferase 4 Mus musculus (Mouse) PR
Q8S8S2 LPEAT2 Lysophospholipid acyltransferase LPEAT2 Arabidopsis thaliana (Mouse-ear cress) PR
Q6PBN5 aup1 Lipid droplet-regulating VLDL assembly factor AUP1 Danio rerio (Zebrafish) (Brachydanio rerio) PR
A3KGT9 agpat9l Glycerol-3-phosphate acyltransferase 3-like Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MFLLLPFDSL IVNLLGISLT VLFTLLLVFI IVPAIFGVSF GIRKLYMKSL LKIFAWATLR
70 80 90 100 110 120
MERGAKEKNH QLYKPYTNGI IAKDPTSLEE EIKEIRRSGS SKALDNTPEF ELSDIFYFCR
130 140 150 160 170 180
KGMETIMDDE VTKRFSAEEL ESWNLLSRTN YNFQYISLRL TVLWGLGVLI RYCFLLPLRI
190 200 210 220 230 240
ALAFTGISLL VVGTTVVGYL PNGRFKEFMS KHVHLMCYRI CVRALTAIIT YHDRENRPRN
250 260 270 280 290 300
GGICVANHTS PIDVIILASD GYYAMVGQVH GGLMGVIQRA MVKACPHVWF ERSEVKDRHL
310 320 330 340 350 360
VAKRLTEHVQ DKSKLPILIF PEGTCINNTS VMMFKKGSFE IGATVYPVAI KYDPQFGDAF
370 380 390 400 410 420
WNSSKYGMVT YLLRMMTSWA IVCSVWYLPP MTREADEDAV QFANRVKSAI ARQGGLVDLL
430 440 450
WDGGLKREKV KDTFKEEQQK LYSKMIVGNH KDRSRS